Last 12 months
Inside the activity.
0 purchase rows · 279 sale rows
Disclosed non-derivative P/S rows, by transaction month. Includes amendments and private transactions.Monthly counts
| Month | Purchases | Sales |
|---|---|---|
| Nov 2025 | 0 | 31 |
| Dec 2025 | 0 | 0 |
| Jan 2026 | 0 | 111 |
| Feb 2026 | 0 | 11 |
| Mar 2026 | 0 | 106 |
| Apr 2026 | 0 | 14 |
| May 2026 | 0 | 0 |
| Jun 2026 | 0 | 5 |
| Jul 2026 | 0 | 0 |
| Aug 2026 | 0 | 0 |
| Sep 2026 | 0 | 0 |
| Oct 2026 | 0 | 1 |
Latest available
Insider transactions
Purchases/sales include open-market and private transactions. Plan disclosure applies to the filing; individual rows may differ. “Not disclosed” is not “unplanned.”
The cutoff filters transaction history only. Company summaries and owner relationships show the latest available disclosures. Parser corrections can improve historical records.
| Transaction date | Owner / reported role | Activity / security | Shares / units | Reported price | Reported value | Details |
|---|---|---|---|---|---|---|
| November 12, 2021 Filed Nov 12, 2021 22:52 UTC |
MARAGANORE JOHNDirector · Chief Executive Officer
|
Exercise / conversionCommon Stock | 33,978 | $7.10 | $241,243.80 |
DisclosureSEC source: 0001735276-21-000089 · edgardoc.xml · nonDerivative · entry 1 MARAGANORE JOHN · CIK 0001180432 · Director · Chief Executive Officer 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 248,743 Exercise/conversion can include RSU settlement. Transaction price and option strike are different fields; a missing price is not zero. Derivative and underlying rows can describe the same event. F1 · kind: All sales reported on this Form 4 were made pursuant to a Rule 10b5-1 trading plan adopted by the reporting person on September 9, 2020. The 33,978 options exercised and sold by the reporting person were due to expire on November 30, 2021. Read SEC document |
| October 27, 2021 Filed Oct 29, 2021 20:07 UTC |
SCHULMAN AMY WDirector
|
GrantStock Option (right to buy) · Derivative | 1,814 | $0.00 Strike: $191.16 | $0.00 |
DisclosureSEC source: 0001735276-21-000086 · edgardoc.xml · derivative · entry 1 SCHULMAN AMY W · CIK 0001438226 · Director 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 1,814 Underlying: Common Stock · 1,814 shares Expires 2031-10-26 F1 · derivative.exercise_date: This award vests in full upon the earlier of the first anniversary of the grant date and the date of any earlier retirement or resignation of the Reporting Person, provided such date of retirement or resignation occurs no more than 90 days prior to the first anniversary of the grant date. Read SEC document |
| August 13, 2021 Filed Aug 16, 2021 20:38 UTC |
MARAGANORE JOHNDirector · Chief Executive Officer
|
Exercise / conversionStock Option (right to buy) · Derivative | 33,979 | $0.00 Strike: $7.10 | $0.00 |
DisclosureSEC source: 0001735276-21-000083 · edgardoc.xml · derivative · entry 8 MARAGANORE JOHN · CIK 0001180432 · Director · Chief Executive Officer 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 33,978 Underlying: Common Stock · 33,979 shares Expires 2021-11-30 Exercise/conversion can include RSU settlement. Transaction price and option strike are different fields; a missing price is not zero. Derivative and underlying rows can describe the same event. F1 · kind: All sales reported on this Form 4 were made pursuant to a Rule 10b5-1 trading plan adopted by the reporting person on September 9, 2020. The 33,979 options exercised and sold by the reporting person were due to expire on November 30, 2021. F7 · derivative.exercise_date: The stock option vested as to 25% of the shares on the 1st anniversary of the date of the stock option grant and as to an additional 6.25% of the shares each successive three month period thereafter. Read SEC document |
| August 13, 2021 Filed Aug 16, 2021 20:38 UTC |
MARAGANORE JOHNDirector · Chief Executive Officer
|
SaleCommon Stock | 214 | $201.55 | $43,131.70 |
DisclosureSEC source: 0001735276-21-000083 · edgardoc.xml · nonDerivative · entry 6 MARAGANORE JOHN · CIK 0001180432 · Director · Chief Executive Officer 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 214,765 F1 · kind: All sales reported on this Form 4 were made pursuant to a Rule 10b5-1 trading plan adopted by the reporting person on September 9, 2020. The 33,979 options exercised and sold by the reporting person were due to expire on November 30, 2021. Read SEC document |
| August 13, 2021 Filed Aug 16, 2021 20:38 UTC |
MARAGANORE JOHNDirector · Chief Executive Officer
|
SaleCommon Stock | 3,828 | $200.84 | $768,815.52 |
DisclosureSEC source: 0001735276-21-000083 · edgardoc.xml · nonDerivative · entry 5 MARAGANORE JOHN · CIK 0001180432 · Director · Chief Executive Officer 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 214,979 F1 · kind: All sales reported on this Form 4 were made pursuant to a Rule 10b5-1 trading plan adopted by the reporting person on September 9, 2020. The 33,979 options exercised and sold by the reporting person were due to expire on November 30, 2021. F5 · price: Sale prices ranged from $200.48 to $201.43. Read SEC document |
| August 13, 2021 Filed Aug 16, 2021 20:38 UTC |
MARAGANORE JOHNDirector · Chief Executive Officer
|
SaleCommon Stock | 23,336 | $199.92 | $4,665,333.12 |
DisclosureSEC source: 0001735276-21-000083 · edgardoc.xml · nonDerivative · entry 4 MARAGANORE JOHN · CIK 0001180432 · Director · Chief Executive Officer 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 218,807 F1 · kind: All sales reported on this Form 4 were made pursuant to a Rule 10b5-1 trading plan adopted by the reporting person on September 9, 2020. The 33,979 options exercised and sold by the reporting person were due to expire on November 30, 2021. F4 · price: Sale prices ranged from $199.46 to $200.45. Read SEC document |
| August 13, 2021 Filed Aug 16, 2021 20:38 UTC |
MARAGANORE JOHNDirector · Chief Executive Officer
|
SaleCommon Stock | 4,160 | $198.93 | $827,548.80 |
DisclosureSEC source: 0001735276-21-000083 · edgardoc.xml · nonDerivative · entry 3 MARAGANORE JOHN · CIK 0001180432 · Director · Chief Executive Officer 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 242,143 F1 · kind: All sales reported on this Form 4 were made pursuant to a Rule 10b5-1 trading plan adopted by the reporting person on September 9, 2020. The 33,979 options exercised and sold by the reporting person were due to expire on November 30, 2021. F3 · price: Sale prices ranged from $198.45 to $199.44. Read SEC document |
| August 13, 2021 Filed Aug 16, 2021 20:38 UTC |
MARAGANORE JOHNDirector · Chief Executive Officer
|
SaleCommon Stock | 2,441 | $198.02 | $483,366.82 |
DisclosureSEC source: 0001735276-21-000083 · edgardoc.xml · nonDerivative · entry 2 MARAGANORE JOHN · CIK 0001180432 · Director · Chief Executive Officer 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 246,303 F1 · kind: All sales reported on this Form 4 were made pursuant to a Rule 10b5-1 trading plan adopted by the reporting person on September 9, 2020. The 33,979 options exercised and sold by the reporting person were due to expire on November 30, 2021. F2 · price: Sale prices ranged from $197.44 to $198.44. Read SEC document |
| August 13, 2021 Filed Aug 16, 2021 20:38 UTC |
MARAGANORE JOHNDirector · Chief Executive Officer
|
Exercise / conversionCommon Stock | 33,979 | $7.10 | $241,250.90 |
DisclosureSEC source: 0001735276-21-000083 · edgardoc.xml · nonDerivative · entry 1 MARAGANORE JOHN · CIK 0001180432 · Director · Chief Executive Officer 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 248,744 Exercise/conversion can include RSU settlement. Transaction price and option strike are different fields; a missing price is not zero. Derivative and underlying rows can describe the same event. F1 · kind: All sales reported on this Form 4 were made pursuant to a Rule 10b5-1 trading plan adopted by the reporting person on September 9, 2020. The 33,979 options exercised and sold by the reporting person were due to expire on November 30, 2021. Read SEC document |
| August 09, 2021 Filed Aug 11, 2021 20:10 UTC |
Vaishnaw AkshayPresident, R&D
|
Exercise / conversionPerformance Stock Option 2013 (right to buy) · Derivative | 10,834 | $0.00 Strike: $63.00 | $0.00 |
DisclosureSEC source: 0001735276-21-000081 · edgardoc.xml · derivative · entry 4 Vaishnaw Akshay · CIK 0001458494 · President, R&D 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 10,832 Underlying: Common Stock · 10,834 shares Expires 2023-12-17 Exercise/conversion can include RSU settlement. Transaction price and option strike are different fields; a missing price is not zero. Derivative and underlying rows can describe the same event. F1 · kind: All sales reported on this Form 4 were made pursuant to a Rule 10b5-1 trading plan adopted by the reporting person on February 15, 2021. Read SEC document |
| August 09, 2021 Filed Aug 11, 2021 20:10 UTC |
Vaishnaw AkshayPresident, R&D
|
SaleCommon Stock | 10,834 | $200.00 | $2,166,800.00 |
DisclosureSEC source: 0001735276-21-000081 · edgardoc.xml · nonDerivative · entry 2 Vaishnaw Akshay · CIK 0001458494 · President, R&D 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 11,215 F1 · kind: All sales reported on this Form 4 were made pursuant to a Rule 10b5-1 trading plan adopted by the reporting person on February 15, 2021. Read SEC document |
| August 09, 2021 Filed Aug 11, 2021 20:10 UTC |
Vaishnaw AkshayPresident, R&D
|
Exercise / conversionCommon Stock | 10,834 | $63.00 | $682,542.00 |
DisclosureSEC source: 0001735276-21-000081 · edgardoc.xml · nonDerivative · entry 1 Vaishnaw Akshay · CIK 0001458494 · President, R&D 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 22,049 Exercise/conversion can include RSU settlement. Transaction price and option strike are different fields; a missing price is not zero. Derivative and underlying rows can describe the same event. F1 · kind: All sales reported on this Form 4 were made pursuant to a Rule 10b5-1 trading plan adopted by the reporting person on February 15, 2021. Read SEC document |
| August 06, 2021 Filed Aug 9, 2021 20:09 UTC |
Greenstreet YvonnePresident & COO
|
Exercise / conversionStock Option (right to buy) · Derivative | 28,064 | $0.00 Strike: $77.10 | $0.00 |
DisclosureSEC source: 0001735276-21-000078 · edgardoc.xml · derivative · entry 6 Greenstreet Yvonne · CIK 0001446125 · President & COO 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 0 Underlying: Common Stock · 28,064 shares Expires 2026-09-18 Exercise/conversion can include RSU settlement. Transaction price and option strike are different fields; a missing price is not zero. Derivative and underlying rows can describe the same event. F1 · kind: All sales reported on this Form 4 were made pursuant to a Rule 10b5-1 trading plan adopted by the reporting person on February 12, 2021. F3 · derivative.exercise_date: The stock option vested as to 25% of the shares on the 1st anniversary of the date of the stock option grant and as to an additional 6.25% of the shares each successive three month period thereafter. Read SEC document |
| August 06, 2021 Filed Aug 9, 2021 20:09 UTC |
Greenstreet YvonnePresident & COO
|
Exercise / conversionPerformance Stock Option 2016 (right to buy) · Derivative | 25,000 | $0.00 Strike: $77.10 | $0.00 |
DisclosureSEC source: 0001735276-21-000078 · edgardoc.xml · derivative · entry 5 Greenstreet Yvonne · CIK 0001446125 · President & COO 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 0 Underlying: Common Stock · 25,000 shares Expires 2026-09-18 Exercise/conversion can include RSU settlement. Transaction price and option strike are different fields; a missing price is not zero. Derivative and underlying rows can describe the same event. F1 · kind: All sales reported on this Form 4 were made pursuant to a Rule 10b5-1 trading plan adopted by the reporting person on February 12, 2021. Read SEC document |
| August 06, 2021 Filed Aug 9, 2021 20:09 UTC |
Greenstreet YvonnePresident & COO
|
SaleCommon Stock | 53,064 | $199.00 | $10,559,736.00 |
DisclosureSEC source: 0001735276-21-000078 · edgardoc.xml · nonDerivative · entry 3 Greenstreet Yvonne · CIK 0001446125 · President & COO 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 11,023 F1 · kind: All sales reported on this Form 4 were made pursuant to a Rule 10b5-1 trading plan adopted by the reporting person on February 12, 2021. Read SEC document |
| August 06, 2021 Filed Aug 9, 2021 20:09 UTC |
Greenstreet YvonnePresident & COO
|
Exercise / conversionCommon Stock | 25,000 | $77.10 | $1,927,500.00 |
DisclosureSEC source: 0001735276-21-000078 · edgardoc.xml · nonDerivative · entry 2 Greenstreet Yvonne · CIK 0001446125 · President & COO 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 64,087 Exercise/conversion can include RSU settlement. Transaction price and option strike are different fields; a missing price is not zero. Derivative and underlying rows can describe the same event. F1 · kind: All sales reported on this Form 4 were made pursuant to a Rule 10b5-1 trading plan adopted by the reporting person on February 12, 2021. Read SEC document |
| August 06, 2021 Filed Aug 9, 2021 20:09 UTC |
Greenstreet YvonnePresident & COO
|
Exercise / conversionCommon Stock | 28,064 | $77.10 | $2,163,734.40 |
DisclosureSEC source: 0001735276-21-000078 · edgardoc.xml · nonDerivative · entry 1 Greenstreet Yvonne · CIK 0001446125 · President & COO 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 39,087 Exercise/conversion can include RSU settlement. Transaction price and option strike are different fields; a missing price is not zero. Derivative and underlying rows can describe the same event. F1 · kind: All sales reported on this Form 4 were made pursuant to a Rule 10b5-1 trading plan adopted by the reporting person on February 12, 2021. Read SEC document |
| August 05, 2021 Filed Aug 9, 2021 20:09 UTC |
KEATING LAURIEEVP, Chief Legal Officer
|
Exercise / conversionStock Option (right to buy) · Derivative | 7,876 | $0.00 Strike: $88.95 | $0.00 |
DisclosureSEC source: 0001735276-21-000079 · edgardoc.xml · derivative · entry 6 KEATING LAURIE · CIK 0001620743 · EVP, Chief Legal Officer 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 1,124 Underlying: Common Stock · 7,876 shares Expires 2025-12-18 Exercise/conversion can include RSU settlement. Transaction price and option strike are different fields; a missing price is not zero. Derivative and underlying rows can describe the same event. F1 · kind: All sales reported on this Form 4 were made pursuant to a Rule 10b5-1 trading plan adopted by the reporting person on September 10, 2020. F3 · derivative.exercise_date: The stock option vested as to 25% of the shares on the 1st anniversary of the date of the stock option grant and as to an additional 6.25% of the shares each successive three month period thereafter. Read SEC document |
| August 05, 2021 Filed Aug 9, 2021 20:09 UTC |
KEATING LAURIEEVP, Chief Legal Officer
|
Exercise / conversionPerformance Stock Option 2015 (right to buy) · Derivative | 2,124 | $0.00 Strike: $88.95 | $0.00 |
DisclosureSEC source: 0001735276-21-000079 · edgardoc.xml · derivative · entry 5 KEATING LAURIE · CIK 0001620743 · EVP, Chief Legal Officer 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 11,876 Underlying: Common Stock · 2,124 shares Expires 2025-12-18 Exercise/conversion can include RSU settlement. Transaction price and option strike are different fields; a missing price is not zero. Derivative and underlying rows can describe the same event. F1 · kind: All sales reported on this Form 4 were made pursuant to a Rule 10b5-1 trading plan adopted by the reporting person on September 10, 2020. Read SEC document |
| August 05, 2021 Filed Aug 9, 2021 20:09 UTC |
KEATING LAURIEEVP, Chief Legal Officer
|
SaleCommon Stock | 10,000 | $188.95 | $1,889,500.00 |
DisclosureSEC source: 0001735276-21-000079 · edgardoc.xml · nonDerivative · entry 3 KEATING LAURIE · CIK 0001620743 · EVP, Chief Legal Officer 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 5,132 F1 · kind: All sales reported on this Form 4 were made pursuant to a Rule 10b5-1 trading plan adopted by the reporting person on September 10, 2020. Read SEC document |
| August 05, 2021 Filed Aug 9, 2021 20:09 UTC |
KEATING LAURIEEVP, Chief Legal Officer
|
Exercise / conversionCommon Stock | 2,124 | $88.95 | $188,929.80 |
DisclosureSEC source: 0001735276-21-000079 · edgardoc.xml · nonDerivative · entry 2 KEATING LAURIE · CIK 0001620743 · EVP, Chief Legal Officer 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 15,132 Exercise/conversion can include RSU settlement. Transaction price and option strike are different fields; a missing price is not zero. Derivative and underlying rows can describe the same event. F1 · kind: All sales reported on this Form 4 were made pursuant to a Rule 10b5-1 trading plan adopted by the reporting person on September 10, 2020. Read SEC document |
| August 05, 2021 Filed Aug 9, 2021 20:09 UTC |
KEATING LAURIEEVP, Chief Legal Officer
|
Exercise / conversionCommon Stock | 7,876 | $88.95 | $700,570.20 |
DisclosureSEC source: 0001735276-21-000079 · edgardoc.xml · nonDerivative · entry 1 KEATING LAURIE · CIK 0001620743 · EVP, Chief Legal Officer 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 13,008 Exercise/conversion can include RSU settlement. Transaction price and option strike are different fields; a missing price is not zero. Derivative and underlying rows can describe the same event. F1 · kind: All sales reported on this Form 4 were made pursuant to a Rule 10b5-1 trading plan adopted by the reporting person on September 10, 2020. Read SEC document |
| August 02, 2021 Filed Aug 3, 2021 23:31 UTC |
BONNEY MICHAEL WDirector · Executive Chair
|
GrantRestricted Stock Units · Derivative | 22,477 | $0.00 | $0.00 |
DisclosureSEC source: 0001735276-21-000075 · edgardoc.xml · derivative · entry 1 BONNEY MICHAEL W · CIK 0001219016 · Director · Executive Chair 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 22,477 Underlying: Common Stock · 22,477 shares Expires not disclosed F1 · derivative.exercise_price: Each restricted stock unit represents a contingent right to receive one share of ALNY common stock. F2 · derivative.exercise_date: The restricted stock units vest in full on the earlier of August 2, 2023 and the date the Reporting Person ceases to serve as a director of the Company other than for cause or by his voluntary resignation as Executive Chair without the consent of the Board of Directors. F2 · derivative.expiration_date: The restricted stock units vest in full on the earlier of August 2, 2023 and the date the Reporting Person ceases to serve as a director of the Company other than for cause or by his voluntary resignation as Executive Chair without the consent of the Board of Directors. Read SEC document |
| July 15, 2021 Filed Jul 19, 2021 20:23 UTC |
PYOTT DAVID E IDirector
|
GrantStock Option (right to buy) · Derivative | 4,032 | $0.00 Strike: $171.95 | $0.00 |
DisclosureSEC source: 0001735276-21-000073 · edgardoc.xml · derivative · entry 1 PYOTT DAVID E I · CIK 0001051578 · Director 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 4,032 Underlying: Common Stock · 4,032 shares Expires 2031-07-14 F1 · derivative.exercise_date: This award vests in full upon the earlier of the first anniversary of the grant date and the date of any earlier retirement or resignation of the Reporting Person, provided such date of retirement or resignation occurs no more than 90 days prior to the first anniversary of the grant date. Read SEC document |
| July 15, 2021 Filed Jul 19, 2021 20:19 UTC |
Fanucci MarshaDirector
|
GrantStock Option (right to buy) · Derivative | 4,032 | $0.00 Strike: $171.95 | $0.00 |
DisclosureSEC source: 0001735276-21-000065 · edgardoc.xml · derivative · entry 1 Fanucci Marsha · CIK 0001298814 · Director 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 4,032 Underlying: Common Stock · 4,032 shares Expires 2031-07-14 F1 · derivative.exercise_date: This award vests in full upon the earlier of the first anniversary of the grant date and the date of any earlier retirement or resignation of the Reporting Person, provided such date of retirement or resignation occurs no more than 90 days prior to the first anniversary of the grant date. Read SEC document |
| July 15, 2021 Filed Jul 19, 2021 20:22 UTC |
BRANDICOURT OLIVIERDirector
|
GrantStock Option (right to buy) · Derivative | 4,032 | $0.00 Strike: $171.95 | $0.00 |
DisclosureSEC source: 0001735276-21-000072 · edgardoc.xml · derivative · entry 1 BRANDICOURT OLIVIER · CIK 0001508518 · Director 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 4,032 Underlying: Common Stock · 4,032 shares Expires 2031-07-14 F1 · derivative.exercise_date: This award vests in full upon the earlier of the first anniversary of the grant date and the date of any earlier retirement or resignation of the Reporting Person, provided such date of retirement or resignation occurs no more than 90 days prior to the first anniversary of the grant date. Read SEC document |
| July 15, 2021 Filed Jul 19, 2021 20:22 UTC |
HAMBURG MARGARET ADirector
|
GrantStock Option (right to buy) · Derivative | 4,032 | $0.00 Strike: $171.95 | $0.00 |
DisclosureSEC source: 0001735276-21-000071 · edgardoc.xml · derivative · entry 1 HAMBURG MARGARET A · CIK 0001266917 · Director 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 4,032 Underlying: Common Stock · 4,032 shares Expires 2031-07-14 F1 · derivative.exercise_date: This award vests in full upon the earlier of the first anniversary of the grant date and the date of any earlier retirement or resignation of the Reporting Person, provided such date of retirement or resignation occurs no more than 90 days prior to the first anniversary of the grant date. Read SEC document |
| July 15, 2021 Filed Jul 19, 2021 20:22 UTC |
Reitan Colleen FDirector
|
GrantStock Option (right to buy) · Derivative | 4,032 | $0.00 Strike: $171.95 | $0.00 |
DisclosureSEC source: 0001735276-21-000070 · edgardoc.xml · derivative · entry 1 Reitan Colleen F · CIK 0001740730 · Director 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 4,032 Underlying: Common Stock · 4,032 shares Expires 2031-07-14 F1 · derivative.exercise_date: This award vests in full upon the earlier of the first anniversary of the grant date and the date of any earlier retirement or resignation of the Reporting Person, provided such date of retirement or resignation occurs no more than 90 days prior to the first anniversary of the grant date. Read SEC document |
| July 15, 2021 Filed Jul 19, 2021 20:21 UTC |
BONNEY MICHAEL WDirector
|
GrantStock Option (right to buy) · Derivative | 4,032 | $0.00 Strike: $171.95 | $0.00 |
DisclosureSEC source: 0001735276-21-000069 · edgardoc.xml · derivative · entry 1 BONNEY MICHAEL W · CIK 0001219016 · Director 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 4,032 Underlying: Common Stock · 4,032 shares Expires 2031-07-14 F1 · derivative.exercise_date: This award vests in full upon the earlier of the first anniversary of the grant date and the date of any earlier retirement or resignation of the Reporting Person, provided such date of retirement or resignation occurs no more than 90 days prior to the first anniversary of the grant date. Read SEC document |
| July 15, 2021 Filed Jul 19, 2021 20:21 UTC |
SCHULMAN AMY WDirector
|
GrantStock Option (right to buy) · Derivative | 4,032 | $0.00 Strike: $171.95 | $0.00 |
DisclosureSEC source: 0001735276-21-000068 · edgardoc.xml · derivative · entry 1 SCHULMAN AMY W · CIK 0001438226 · Director 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 4,032 Underlying: Common Stock · 4,032 shares Expires 2031-07-14 F1 · derivative.exercise_date: This award vests in full upon the earlier of the first anniversary of the grant date and the date of any earlier retirement or resignation of the Reporting Person, provided such date of retirement or resignation occurs no more than 90 days prior to the first anniversary of the grant date. Read SEC document |
| July 15, 2021 Filed Jul 19, 2021 20:20 UTC |
Ausiello Dennis ADirector
|
GrantStock Option (right to buy) · Derivative | 4,032 | $0.00 Strike: $171.95 | $0.00 |
DisclosureSEC source: 0001735276-21-000067 · edgardoc.xml · derivative · entry 1 Ausiello Dennis A · CIK 0001381994 · Director 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 4,032 Underlying: Common Stock · 4,032 shares Expires 2031-07-14 F1 · derivative.exercise_date: This award vests in full upon the earlier of the first anniversary of the grant date and the date of any earlier retirement or resignation of the Reporting Person, provided such date of retirement or resignation occurs no more than 90 days prior to the first anniversary of the grant date. Read SEC document |
| July 15, 2021 Filed Jul 19, 2021 20:20 UTC |
PAUL STEVEN MDirector
|
GrantStock Option (right to buy) · Derivative | 4,032 | $0.00 Strike: $171.95 | $0.00 |
DisclosureSEC source: 0001735276-21-000066 · edgardoc.xml · derivative · entry 1 PAUL STEVEN M · CIK 0001237564 · Director 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 4,032 Underlying: Common Stock · 4,032 shares Expires 2031-07-14 F1 · derivative.exercise_date: This award vests in full upon the earlier of the first anniversary of the grant date and the date of any earlier retirement or resignation of the Reporting Person, provided such date of retirement or resignation occurs no more than 90 days prior to the first anniversary of the grant date. Read SEC document |
| July 15, 2021 Filed Jul 19, 2021 20:18 UTC |
SHARP PHILLIP ADirector
|
GrantStock Option (right to buy) · Derivative | 4,032 | $0.00 Strike: $171.95 | $0.00 |
DisclosureSEC source: 0001735276-21-000064 · edgardoc.xml · derivative · entry 1 SHARP PHILLIP A · CIK 0001226295 · Director 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 4,032 Underlying: Common Stock · 4,032 shares Expires 2031-07-14 F1 · derivative.exercise_date: This award vests in full upon the earlier of the first anniversary of the grant date and the date of any earlier retirement or resignation of the Reporting Person, provided such date of retirement or resignation occurs no more than 90 days prior to the first anniversary of the grant date. Read SEC document |
| July 12, 2021 Filed Jul 14, 2021 20:58 UTC |
KEATING LAURIEEVP, Chief Legal Officer
|
Exercise / conversionStock Option (right to buy) · Derivative | 5,000 | $0.00 Strike: $88.95 | $0.00 |
DisclosureSEC source: 0001735276-21-000053 · edgardoc.xml · derivative · entry 7 KEATING LAURIE · CIK 0001620743 · EVP, Chief Legal Officer 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 9,000 Underlying: Common Stock · 5,000 shares Expires 2025-12-18 Exercise/conversion can include RSU settlement. Transaction price and option strike are different fields; a missing price is not zero. Derivative and underlying rows can describe the same event. F1 · kind: All sales reported on this Form 4 were made pursuant to a Rule 10b5-1 trading plan adopted by the reporting person on September 10, 2020. F3 · derivative.exercise_date: The stock option vested as to 25% of the shares on the 1st anniversary of the date of the stock option grant and as to an additional 6.25% of the shares each successive three month period thereafter. Read SEC document |
| July 12, 2021 Filed Jul 14, 2021 20:58 UTC |
KEATING LAURIEEVP, Chief Legal Officer
|
Exercise / conversionStock Option (right to buy) · Derivative | 1,812 | $0.00 Strike: $85.00 | $0.00 |
DisclosureSEC source: 0001735276-21-000053 · edgardoc.xml · derivative · entry 6 KEATING LAURIE · CIK 0001620743 · EVP, Chief Legal Officer 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 17,188 Underlying: Common Stock · 1,812 shares Expires 2029-02-27 Exercise/conversion can include RSU settlement. Transaction price and option strike are different fields; a missing price is not zero. Derivative and underlying rows can describe the same event. F1 · kind: All sales reported on this Form 4 were made pursuant to a Rule 10b5-1 trading plan adopted by the reporting person on September 10, 2020. F3 · derivative.exercise_date: The stock option vested as to 25% of the shares on the 1st anniversary of the date of the stock option grant and as to an additional 6.25% of the shares each successive three month period thereafter. Read SEC document |
| July 12, 2021 Filed Jul 14, 2021 20:58 UTC |
KEATING LAURIEEVP, Chief Legal Officer
|
SaleCommon Stock | 5,000 | $178.95 | $894,750.00 |
DisclosureSEC source: 0001735276-21-000053 · edgardoc.xml · nonDerivative · entry 4 KEATING LAURIE · CIK 0001620743 · EVP, Chief Legal Officer 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 5,132 F1 · kind: All sales reported on this Form 4 were made pursuant to a Rule 10b5-1 trading plan adopted by the reporting person on September 10, 2020. Read SEC document |
| July 12, 2021 Filed Jul 14, 2021 20:58 UTC |
KEATING LAURIEEVP, Chief Legal Officer
|
SaleCommon Stock | 1,812 | $179.00 | $324,348.00 |
DisclosureSEC source: 0001735276-21-000053 · edgardoc.xml · nonDerivative · entry 3 KEATING LAURIE · CIK 0001620743 · EVP, Chief Legal Officer 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 10,132 F1 · kind: All sales reported on this Form 4 were made pursuant to a Rule 10b5-1 trading plan adopted by the reporting person on September 10, 2020. Read SEC document |
| July 12, 2021 Filed Jul 14, 2021 20:58 UTC |
KEATING LAURIEEVP, Chief Legal Officer
|
Exercise / conversionCommon Stock | 5,000 | $88.95 | $444,750.00 |
DisclosureSEC source: 0001735276-21-000053 · edgardoc.xml · nonDerivative · entry 2 KEATING LAURIE · CIK 0001620743 · EVP, Chief Legal Officer 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 11,944 Exercise/conversion can include RSU settlement. Transaction price and option strike are different fields; a missing price is not zero. Derivative and underlying rows can describe the same event. F1 · kind: All sales reported on this Form 4 were made pursuant to a Rule 10b5-1 trading plan adopted by the reporting person on September 10, 2020. Read SEC document |
| July 12, 2021 Filed Jul 14, 2021 20:58 UTC |
KEATING LAURIEEVP, Chief Legal Officer
|
Exercise / conversionCommon Stock | 1,812 | $85.00 | $154,020.00 |
DisclosureSEC source: 0001735276-21-000053 · edgardoc.xml · nonDerivative · entry 1 KEATING LAURIE · CIK 0001620743 · EVP, Chief Legal Officer 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 6,944 Exercise/conversion can include RSU settlement. Transaction price and option strike are different fields; a missing price is not zero. Derivative and underlying rows can describe the same event. F1 · kind: All sales reported on this Form 4 were made pursuant to a Rule 10b5-1 trading plan adopted by the reporting person on September 10, 2020. Read SEC document |
| June 18, 2021 Filed Jun 22, 2021 20:07 UTC |
Vaishnaw AkshayPresident, R&D
|
Exercise / conversionStock Option (right to buy) · Derivative | 970 | $0.00 Strike: $42.22 | $0.00 |
DisclosureSEC source: 0001735276-21-000051 · edgardoc.xml · derivative · entry 6 Vaishnaw Akshay · CIK 0001458494 · President, R&D 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 2,368 Underlying: Common Stock · 970 shares Expires 2026-12-20 Exercise/conversion can include RSU settlement. Transaction price and option strike are different fields; a missing price is not zero. Derivative and underlying rows can describe the same event. F1 · kind: All sales reported on this Form 4 were made pursuant to a Rule 10b5-1 trading plan adopted by the reporting person on February 15, 2021. F3 · derivative.exercise_date: The stock option vested as to 25% of the shares on the 1st anniversary of the date of the stock option grant and as to an additional 6.25% of the shares each successive three month period thereafter. Read SEC document |
| June 18, 2021 Filed Jun 22, 2021 20:07 UTC |
Vaishnaw AkshayPresident, R&D
|
Exercise / conversionPerformance Stock Option 2013 (right to buy) · Derivative | 10,834 | $0.00 Strike: $63.00 | $0.00 |
DisclosureSEC source: 0001735276-21-000051 · edgardoc.xml · derivative · entry 5 Vaishnaw Akshay · CIK 0001458494 · President, R&D 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 21,666 Underlying: Common Stock · 10,834 shares Expires 2023-12-17 Exercise/conversion can include RSU settlement. Transaction price and option strike are different fields; a missing price is not zero. Derivative and underlying rows can describe the same event. F1 · kind: All sales reported on this Form 4 were made pursuant to a Rule 10b5-1 trading plan adopted by the reporting person on February 15, 2021. Read SEC document |
| June 18, 2021 Filed Jun 22, 2021 20:07 UTC |
Vaishnaw AkshayPresident, R&D
|
SaleCommon Stock | 14,708 | $175.00 | $2,573,900.00 |
DisclosureSEC source: 0001735276-21-000051 · edgardoc.xml · nonDerivative · entry 3 Vaishnaw Akshay · CIK 0001458494 · President, R&D 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 11,215 F1 · kind: All sales reported on this Form 4 were made pursuant to a Rule 10b5-1 trading plan adopted by the reporting person on February 15, 2021. Read SEC document |
| June 18, 2021 Filed Jun 22, 2021 20:07 UTC |
Vaishnaw AkshayPresident, R&D
|
Exercise / conversionCommon Stock | 970 | $42.22 | $40,953.40 |
DisclosureSEC source: 0001735276-21-000051 · edgardoc.xml · nonDerivative · entry 2 Vaishnaw Akshay · CIK 0001458494 · President, R&D 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 25,923 Exercise/conversion can include RSU settlement. Transaction price and option strike are different fields; a missing price is not zero. Derivative and underlying rows can describe the same event. F1 · kind: All sales reported on this Form 4 were made pursuant to a Rule 10b5-1 trading plan adopted by the reporting person on February 15, 2021. Read SEC document |
| June 18, 2021 Filed Jun 22, 2021 20:07 UTC |
Vaishnaw AkshayPresident, R&D
|
Exercise / conversionCommon Stock | 10,834 | $63.00 | $682,542.00 |
DisclosureSEC source: 0001735276-21-000051 · edgardoc.xml · nonDerivative · entry 1 Vaishnaw Akshay · CIK 0001458494 · President, R&D 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 24,953 Exercise/conversion can include RSU settlement. Transaction price and option strike are different fields; a missing price is not zero. Derivative and underlying rows can describe the same event. F1 · kind: All sales reported on this Form 4 were made pursuant to a Rule 10b5-1 trading plan adopted by the reporting person on February 15, 2021. Read SEC document |
| June 09, 2021 Filed Jun 11, 2021 20:13 UTC |
KEATING LAURIEEVP, Chief Legal Officer
|
SaleCommon Stock | 1,734 | $154.00 | $267,036.00 |
DisclosureSEC source: 0001735276-21-000047 · edgardoc.xml · nonDerivative · entry 1 KEATING LAURIE · CIK 0001620743 · EVP, Chief Legal Officer 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 5,132 F1 · kind: All sales reported on this Form 4 were made pursuant to a Rule 10b5-1 trading plan adopted by the reporting person on September 10, 2020. Read SEC document |
| May 13, 2021 Filed May 17, 2021 23:25 UTC |
MARAGANORE JOHNDirector · Chief Executive Officer
|
Exercise / conversionStock Option (right to buy) · Derivative | 33,979 | $0.00 Strike: $7.10 | $0.00 |
DisclosureSEC source: 0001735276-21-000044 · edgardoc.xml · derivative · entry 10 MARAGANORE JOHN · CIK 0001180432 · Director · Chief Executive Officer 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 67,957 Underlying: Common Stock · 33,979 shares Expires 2021-11-30 Exercise/conversion can include RSU settlement. Transaction price and option strike are different fields; a missing price is not zero. Derivative and underlying rows can describe the same event. F1 · kind: All sales reported on this Form 4 were made pursuant to a Rule 10b5-1 trading plan adopted by the reporting person on September 9, 2020. The 33,979 options exercised and sold by the reporting person were due to expire on November 30, 2021. F10 · derivative.exercise_date: The stock option vested as to 25% of the shares on the 1st anniversary of the date of the stock option grant and as to an additional 6.25% of the shares each successive three month period thereafter. Read SEC document |
| May 13, 2021 Filed May 17, 2021 23:25 UTC |
MARAGANORE JOHNDirector · Chief Executive Officer
|
SaleCommon Stock | 1,023 | $134.37 | $137,460.51 |
DisclosureSEC source: 0001735276-21-000044 · edgardoc.xml · nonDerivative · entry 8 MARAGANORE JOHN · CIK 0001180432 · Director · Chief Executive Officer 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 214,765 F1 · kind: All sales reported on this Form 4 were made pursuant to a Rule 10b5-1 trading plan adopted by the reporting person on September 9, 2020. The 33,979 options exercised and sold by the reporting person were due to expire on November 30, 2021. F8 · price: Sale prices ranged from $134.11 to $134.40. Read SEC document |
| May 13, 2021 Filed May 17, 2021 23:25 UTC |
MARAGANORE JOHNDirector · Chief Executive Officer
|
SaleCommon Stock | 1,624 | $133.56 | $216,901.44 |
DisclosureSEC source: 0001735276-21-000044 · edgardoc.xml · nonDerivative · entry 7 MARAGANORE JOHN · CIK 0001180432 · Director · Chief Executive Officer 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 215,788 F1 · kind: All sales reported on this Form 4 were made pursuant to a Rule 10b5-1 trading plan adopted by the reporting person on September 9, 2020. The 33,979 options exercised and sold by the reporting person were due to expire on November 30, 2021. F7 · price: Sale prices ranged from $132.97 to $133.77. Read SEC document |
| May 13, 2021 Filed May 17, 2021 23:25 UTC |
MARAGANORE JOHNDirector · Chief Executive Officer
|
SaleCommon Stock | 3,481 | $132.32 | $460,605.92 |
DisclosureSEC source: 0001735276-21-000044 · edgardoc.xml · nonDerivative · entry 6 MARAGANORE JOHN · CIK 0001180432 · Director · Chief Executive Officer 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 217,412 F1 · kind: All sales reported on this Form 4 were made pursuant to a Rule 10b5-1 trading plan adopted by the reporting person on September 9, 2020. The 33,979 options exercised and sold by the reporting person were due to expire on November 30, 2021. F6 · price: Sale prices ranged from $131.84 to $132.78. Read SEC document |
| May 13, 2021 Filed May 17, 2021 23:25 UTC |
MARAGANORE JOHNDirector · Chief Executive Officer
|
SaleCommon Stock | 11,203 | $131.18 | $1,469,609.54 |
DisclosureSEC source: 0001735276-21-000044 · edgardoc.xml · nonDerivative · entry 5 MARAGANORE JOHN · CIK 0001180432 · Director · Chief Executive Officer 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 220,893 F1 · kind: All sales reported on this Form 4 were made pursuant to a Rule 10b5-1 trading plan adopted by the reporting person on September 9, 2020. The 33,979 options exercised and sold by the reporting person were due to expire on November 30, 2021. F5 · price: Sale prices ranged from $130.82 to $131.81. Read SEC document |
Value uses the disclosed total when available, otherwise shares × reported transaction price. It is not an estimate of exercise cash cost or investment performance.